ANIXA BIOSCIENCES, INC. Depreciation
ANIXA BIOSCIENCES, INC. (ANIX) reported Depreciation of $38.28 thousand for the 12-month period ending 2020-10-31, per its 10-K filed 2022-01-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2022-01-04
- ANIXA BIOSCIENCES, INC. depreciation for the quarter ending 2020-10-31 was $0.00, a 100.00% decline year-over-year.
- ANIXA BIOSCIENCES, INC. depreciation for the quarter ending 2020-07-31 was $8.86K, a 40.48% decline year-over-year.
- ANIXA BIOSCIENCES, INC. depreciation for the quarter ending 2020-04-30 was $14.42K, a 20.39% increase year-over-year.
- ANIXA BIOSCIENCES, INC. depreciation for the quarter ending 2020-01-31 was $15.00K, a 144.67% increase year-over-year.
- ANIXA BIOSCIENCES, INC. depreciation for fiscal 2020 was $38.28K, a 19.52% decline from fiscal 2019.
- ANIXA BIOSCIENCES, INC. depreciation for fiscal 2019 was $47.56K, a 157.98% increase from fiscal 2018.
- ANIXA BIOSCIENCES, INC. depreciation for fiscal 2018 was $18.43K.
- ANIXA BIOSCIENCES, INC. depreciation for fiscal 2011 was $7.98K, a 4.56% decline from fiscal 2010.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2020-10-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-01-04 | $8.86K derived: sum of 2 quarters · filed 2022-01-04 | $23.28K derived: sum of 3 quarters · filed 2022-01-04 | $38.28K 10-K · filed 2022-01-04 |
| 2020-07-31 | $8.86K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-09-01 | $23.28K derived: sum of 2 quarters · filed 2021-09-01 | $38.28K 10-Q · filed 2021-09-01 | $52.84K derived: sum of 4 quarters · filed 2021-09-01 |
| 2020-04-30 | $14.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-06-10 | $29.42K 10-Q · filed 2021-06-10 | $43.99K derived: sum of 3 quarters · filed 2021-06-10 | $58.87K derived: sum of 4 quarters · filed 2021-06-10 |
| 2020-01-31 | $15.00K 10-Q · filed 2021-03-11 | $29.57K derived: sum of 2 quarters · filed 2021-03-11 | $44.45K derived: sum of 3 quarters · filed 2021-03-11 | $56.43K derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-10-31 | $14.57K derived: 10-K 12 month − 10-Q 9 month · filed 2021-01-07 | $29.45K derived: sum of 2 quarters · filed 2021-01-07 | $41.43K derived: sum of 3 quarters · filed 2021-01-07 | $47.56K 10-K · filed 2021-01-07 |
| 2019-07-31 | $14.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-09-08 | $26.86K derived: sum of 2 quarters · filed 2020-09-08 | $32.99K 10-Q · filed 2020-09-08 | $39.01K derived: sum of 4 quarters · filed 2020-09-08 |
| 2019-04-30 | $11.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-06-09 | $18.11K 10-Q · filed 2020-06-09 | $24.13K derived: sum of 3 quarters · filed 2020-06-09 | |
| 2019-01-31 | $6.13K 10-Q · filed 2020-03-09 | $12.15K derived: sum of 2 quarters · filed 2020-03-09 | ||
| 2018-10-31 | $6.02K derived: 10-K 12 month − 10-Q 9 month · filed 2020-01-09 | $18.43K 10-K · filed 2020-01-09 | ||
| 2018-07-31 | $12.41K 10-Q · filed 2019-09-06 | |||
| 2016-01-31 | $3.85K 10-Q · filed 2016-02-19 | |||
| 2015-01-31 | $1.02K 10-Q · filed 2016-02-19 | |||
| 2012-07-31 | $1.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-09-14 | $3.55K derived: sum of 2 quarters · filed 2012-09-14 | $5.62K 10-Q · filed 2012-09-14 | $7.61K derived: sum of 4 quarters · filed 2012-09-14 |
| 2012-04-30 | $1.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-06-14 | $3.91K 10-Q · filed 2012-06-14 | $5.90K derived: sum of 3 quarters · filed 2012-06-14 | $7.90K derived: sum of 4 quarters · filed 2012-09-14 |
| 2012-01-31 | $2.08K 10-Q · filed 2012-03-16 | $4.06K derived: sum of 2 quarters · filed 2012-03-16 | $6.07K derived: sum of 3 quarters · filed 2012-09-14 | $8.12K derived: sum of 4 quarters · filed 2012-09-14 |
| 2011-10-31 | $1.99K derived: 10-K 12 month − 10-Q 9 month · filed 2012-01-30 | $3.99K derived: sum of 2 quarters · filed 2012-09-14 | $6.05K derived: sum of 3 quarters · filed 2012-09-14 | $7.98K 10-K · filed 2012-01-30 |
| 2011-07-31 | $2.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-09-14 | $4.06K derived: sum of 2 quarters · filed 2012-09-14 | $5.99K 10-Q · filed 2012-09-14 | $8.05K derived: sum of 4 quarters · filed 2012-09-14 |
| 2011-04-30 | $2.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-06-14 | $3.98K 10-Q · filed 2012-06-14 | $6.04K derived: sum of 3 quarters · filed 2012-06-14 | |
| 2011-01-31 | $1.93K 10-Q · filed 2012-03-16 | $3.98K derived: sum of 2 quarters · filed 2012-03-16 | ||
| 2010-10-31 | $2.06K derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-01-30 | $8.36K 10-K · filed 2012-01-30 | ||
| 2010-07-31 | $6.30K 10-Q/A · filed 2011-10-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |